PLx Pharma Inc. Business Finance Contracts & Agreements

Amendment No. 1 to Asset Purchase Agreement dated May 26, 2023 by and among PLx Pharma Inc., PLx Opco Inc. and PLx Acquisition Company, LLC (Filed With SEC on May 26, 2023)

Asset Purchase Agreement, dated April 12, 2023, by and among PLx Pharma Inc., PLx Opco Inc. and PLx Acquisition Company, LLC (Filed With SEC on April 12, 2023)

Underwriting Agreement, dated March 3, 2021, by and between PLx Pharma Inc. and Raymond James & Associates, Inc (Filed With SEC on March 3, 2021)

Form of Warrant to Purchase Common Stock (Filed With SEC on November 16, 2020)

Form of Securities Purchase Agreement (Filed With SEC on November 16, 2020)

Form of Registration Rights Agreement (Filed With SEC on November 16, 2020)

Form of Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock (Filed With SEC on March 13, 2020)

Form of Warrant (Filed With SEC on March 13, 2020)

Purchase Agreement, dated as of March 12, 2020, by and among the Company and the investors set forth on the signature pages thereto (Filed With SEC on March 13, 2020)

Registration Rights Agreement, dated as of March 12, 2020, by and among the Company and the investors set forth on the signature pages thereto (Filed With SEC on March 13, 2020)

Form of Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock (Filed With SEC on December 21, 2018)

Form of Warrant (Filed With SEC on December 21, 2018)

Purchase Agreement, dated as of December 20, 2018, by and among the Company and the investors set forth on the signature pages thereto (Filed With SEC on December 21, 2018)

Registration Rights Agreement, dated as of December 20, 2018, by and among the Company and the investors set forth on the signature pages thereto (Filed With SEC on December 21, 2018)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 10, 2017)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 10, 2017)

COMMON STOCK PURCHASE WARRANT PLX PHARMA INC. (Filed With SEC on June 12, 2017)

[__________] Shares* PLx Pharma Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 15, 2016)

[__________] Shares* PLx Pharma Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 5, 2016)

PLX PHARMA INC. UNDERWRITING AGREEMENT (Filed With SEC on October 5, 2015)

1,480,000 Shares Dipexium Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 25, 2015)

2,750,000 Shares Dipexium Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 18, 2014)

Shares Dipexium Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 24, 2014)

ASSET PURCHASE AGREEMENT between DIPEXIUM PHARMACEUTICALS, LLC and THE GENAERA LIQUIDATING TRUST, ARGYCE, LLC, as Trustee Dated April 8, 2010 (Filed With SEC on February 6, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 6, 2014)

COMMON STOCK PURCHASE WARRANT To Purchase Class A Membership Interests of DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

COMMON STOCK PURCHASE VV ARRANT To Purchase 500 Class A Membership Interests of DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

COMMON STOCK PURCHASE WARRANT To Purchase Class A Membership Interests of DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

MEMBERSHIP INTEREST PURCHASE WARRANT To Purchase Class A Membership Interests of DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

COMMON STOCK PURCHASE WARRANT To Purchase Class A Membership Interests of DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

INVESTOR RIGHTS AGREEMENT (Filed With SEC on February 6, 2014)

EXHIBIT A INVESTOR RIGHTS AGREEMENT JOINGER (Filed With SEC on February 6, 2014)